EUVIMEDEUVIMED entdecken
Crossref

Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society

Katsunori Manaka, Sayaka Kato, Ryuichi Sakamoto, Hajime Yamakage, Tsugumi Uema, Shiori Kawai, Megumi Shibata, Izumi Hiratsuka, Sawako Nakachi, Takeshi Onoue, Takefumi Tsuchiya, Michiaki Fukui und 7 weitere

Endocrine Journal · 2024

DOI: 10.1507/endocrj.ej23-0671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2024. Verfasst von Katsunori Manaka und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan. Hauptthemen laut MEDLINE: COVID-19, Metabolic Diseases, Endocrine System Diseases, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Metabolic DiseasesEndocrine System DiseasesSARS-CoV-2HumansJapanCross-Sectional StudiesSurveys and QuestionnairesFemaleMaleSocieties, MedicalEndocrinologistsAdultMiddle AgedEndocrinologyPractice Patterns, Physicians'

Stichwörter der Autor:innen

Coronavirus disease 2019 (COVID-19)Endocrine and metabolic diseasesPandemicPost COVID-19 condition (long COVID)

Autor:innen und Institutionen

  • Department of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
  • Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization, Kyoto Medical Center, Kyoto 612-8555, Japan.
  • Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
  • Second Department of Internal Medicine (Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology), Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0213, Japan.
  • Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan.

Zitieren

APA

Manaka, K., Kato, S., Sakamoto, R., Yamakage, H., Uema, T., Kawai, S., Shibata, M., Hiratsuka, I., Nakachi, S., Onoue, T., Tsuchiya, T., Fukui, M., Hashimoto, K., Suzuki, A., Makita, N., Ogawa, Y., Arima, H., Satoh-Asahara, N., & Masuzaki, H. (2024). Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society. Endocrine Journal. https://doi.org/10.1507/endocrj.ej23-0671

Vancouver

Manaka K, Kato S, Sakamoto R, Yamakage H, Uema T, Kawai S, et al. Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society. Endocrine Journal. 2024. doi:10.1507/endocrj.ej23-0671

BibTeX
@article{Manaka2024,
  author = {Manaka, Katsunori and Kato, Sayaka and Sakamoto, Ryuichi and Yamakage, Hajime and Uema, Tsugumi and Kawai, Shiori and Shibata, Megumi and Hiratsuka, Izumi and Nakachi, Sawako and Onoue, Takeshi and Tsuchiya, Takefumi and Fukui, Michiaki and Hashimoto, Koshi and Suzuki, Atsushi and Makita, Noriko and Ogawa, Yoshihiro and Arima, Hiroshi and Satoh-Asahara, Noriko and Masuzaki, Hiroaki},
  title = {Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society},
  journal = {Endocrine Journal},
  year = {2024},
  doi = {10.1507/endocrj.ej23-0671}
}
Kostenlos starten →